【目的】 观察头穴透刺配合三线排刺针法治疗原发性三叉神经痛的临床疗效。【方法】 选取 2023年 1月至 2024年 10月 三亚市中医院针灸二科门诊及病房收治的64例明确诊断为原发性三叉神经痛的患者作为研究对象，按随机数字表法将患者 随机分为观察组与对照组 ，每组各32例。2组患者均给予常规西医治疗，对照组给予常规针刺治疗，观察组给予头穴透刺 配合三线排刺针法治疗。连续治疗6周。治疗6周后，评价2组临床疗效。观察2组患者治疗前后中医证候积分的变化情况， 以及简化McGill疼痛问卷（SF-MPQ）评分包括疼痛等级指数（PRI）、现时疼痛强度（PPI）及视觉模拟评分法（VAS）的情况。比 较2组患者治疗前后汉密尔顿焦虑量表（HAMA）评分、匹兹堡睡眠质量指数（PSQI）评分的变化情况。并评价2组的安全性及 不良反应的发生情况。【结果】（1）观察组的总有效率为 93.75%（30/32），对照组为 75.00%（24/32），观察组疗效优于对照组， 差异有统计学意义（P＜0.05）。（2）治疗后，2组患者的中医证候积分明显改善（P＜0.05），且观察组在改善中医证候积分方面明显优于对照组，差异有统计学意义（P＜0.05）。（3）治疗后，2组患者的PRI、VAS、PPI评分明显改善（P＜0.05），且观察组 在改善PRI、VAS、PPI评分方面明显优于对照组，差异有统计学意义（P＜0.05）。（4）治疗后，2组患者的HAMA评分、PSQI 评分明显改善（P＜0.05），且观察组在改善 HAMA 评分、PSQI 评分方面明显优于对照组，差异有统计学意义（P＜0.05）。 （5）观察组不良反应发生率为 3.13%（1/32），对照组为 6.25%（2/32），2 组患者的不良反应发生率比较，差异无统计学意义 （P＞0.05）。【结论】 头穴透刺配合三线排刺针法治疗原发性三叉神经痛，能明显减轻患者的疼痛症状，提高患者的生活质量， 疗效显著。

Objective To observe the clinical efficacy of scalp point penetration needling combined with triple-line arrangement needling in treating primary trigeminal neuralgia （PTN）. Methods A total of 64 patients diagnosed with PTN who were treated in the Second Department of Acupuncture and Moxibustion outpatient clinics and wards of Sanya Hospital of Traditional Chinese Medicine between January 2023 and October 2024 were selected as study subjects. Patients were randomly divided into an observation group and a control group using a random number table method， with 32 cases in each group. Both groups received conventional western medicine treatment. The observation group received scalp point penetration needling combined with triple-line arrangement needling，while the control group received conventional acupuncture treatment. The treatment lasted for 6 weeks. After 6 weeks of treatment，clinical efficacy was evaluated by observing changes in traditional Chinese medicine （TCM） syndrome scores，Short-Form McGill Pain Questionnaire （SF-MPQ） scores [including Pain Rating Index （PRI），Present Pain Intensity （PPI），and Visual Analogue Scale （VAS） scores]，Hamilton Anxiety Scale （HAMA） scores，and Pittsburgh Sleep Quality Index （PSQI） scores before and after treatment in both groups. Safety and adverse reactions were also assessed. Results （1） The total effective rate was 93.75% （30/32） in the observation group and 75.00% （24/32） in the control group. The efficacy of the observation group was significantly superior to that of the control group （P＜0.05）.（2） After treatment，TCM syndrome scores were significantly improved in both groups （P＜0.05），and the improvement in the observation group was significantly greater than that in the control group （P＜0.05）.（3） After treatment，PRI，VAS，and PPI scores were significantly improved in both groups （P＜ 0.05），and the improvement in the observation group was significantly greater than that in the control group，with statistically significant difference （P＜0.05）.（4） After treatment， HAMA and PSQI scores were significantly improved in both groups （P＜0.05），and the improvement in the observation group was significantly greater than that in the control group， with statistically significant difference （P＜0.05）. （5） The incidence of adverse reactions was 3.13% （1/32） in the observation group and 6.25% （2/32） in the control group，with no statistically significant difference between the two groups （P＞0.05）. Conclusion Scalp point penetration needling combined with triple-line arrangement needling significantly alleviates pain symptoms and improves quality of life in patients with primary trigeminal neuralgia，demonstrating notable clinical efficacy.

R246.9

海南省自然科学基金资助项目（编号：823RC614）；海南省科技厅重点研发资助项目（编号：ZDYF2022SHFZ129）